FDA Calendar & Milestone Watch

Two Notable Late Analyst Calls For Wednesday, July 11th

Biotech Maven

Cantor Fitzgerald Reaffirms Their Buy Rating on Corium - Markets

Cantor Fitzgerald Reaffirms Their Buy Rating on Corium - Markets

In a report released today, William Tanner from Cantor Fitzgerald reiterated a Buy rating on Corium (NASDAQ: CORI), with a

Comments

Trending News

FEATURED

COMMUNITY

Two Notable Analyst Calls For Monday Afternoon, July 16th

A quick synopsis of two notable analyst calls that could move the following small biotech concerns late in the day

Biotech Maven

Add This 'Arrow' To Your Investment 'Quiver'

Why simple options strategies should be embraced by biotech investors

Biotech Maven

Two Notable Analyst Calls For Thursday Afternoon, July 12th

A quick synopsis of two notable analyst calls that could move the following small biotech concerns late in the day

Biotech Maven

Two Notable Late Analyst Calls For Monday, July 2nd

A quick synopsis of two notable analyst calls that could move the following small biotech concerns late in the day

Biotech Maven

Two Notable Analyst Calls For Thursday, June 28th

A quick synopsis of two notable analyst calls that could move the following small biotech concerns

Biotech Maven

Two Notable Analyst Calls For Tuesday, June 26th

A quick synopsis of two notable analyst calls that could move the following small biotech concerns

Biotech Maven

Pharma Advertising Continues To Go Digital

Biotech and pharma concerns continue to move the bulk of their advertising to digital platforms

Biotech Maven